The first is to convert the apoptosis‐related factor ligand (FasL) in astrocytes into the paracrine death signal pathway of cancer cells, or effect by inhibiting the axon Pathfinder L1 cell adhesion molecule (L1CAM) to promote the growth of glioma. Here, L1CAM is linked to central nervous system cancer.